Varaico: Literature-Extracted Genetic Variants

Gene:AVPR2
Variant:p.W200*
Back to variants list

AVPR2

NM_000054.7:p.W200*

Associated Papers

A small molecule stabilizer rescues the surface expression of nearly all missense variants in a GPCR.

Mighell TL et al.

Nature Structural & Molecular Biology, 2025

40983772 (PubMed )
Supplement: 41594_2025_1659_MOESM4_ESM.xlsx › Fig._1b

A novel deletion mutation of the arginine vasopressin receptor 2 gene in a Japanese infant with nephrogenic diabetes insipidus.

Daitsu T et al.

Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology, 2014

Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.

Fujimoto M et al.

Yonago Acta Medica, 2014

Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).

Armstrong SP et al.

Plos One, 2013

Congenital nephrogenic diabetes insipidus: the current state of affairs.

Wesche D et al.

Pediatric Nephrology (berlin, Germany), 2012

Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.

Böselt I et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 2012

Nephrogenic diabetes insipidus due to a novel AVPR2 mutation.

Sakallioglu O et al.

Journal of Pediatric Endocrinology & Metabolism : Jpem, 2009

AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.

Spanakis E et al.

Journal of Cellular Physiology, 2008

Introducing sense into nonsense in treatments of human genetic diseases.

Linde L et al.

Trends in Genetics : Tig, 2008

Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications.

Tao YX

Pharmacology & Therapeutics, 2006

Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo.

Sangkuhl K et al.

Human Molecular Genetics, 2004

Aminoglycoside pretreatment partially restores the function of truncated V(2) vasopressin receptors found in patients with nephrogenic diabetes insipidus.

Schulz A et al.

The Journal of Clinical Endocrinology and Metabolism, 2002

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."